Physician profile
Cristy Dehoff
NPI 1194795328
$7,779.80
in general payments reported to CMS, 2019-2025
20 companies · $728 in 2025
The $728 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,548 · 2020: $302 · 2021: $744 · 2022: $808 · 2023: $1,174 · 2024: $1,475 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,150 · Entertainment: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,150.27 |
| Entertainment | $226.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,351.80 | 2019-2021 | |
| Alcon Vision LLC | $2,151.02 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $963.53 | 2022-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $504.93 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Biofinity Contact Lens |
| Optos, INC. | $362.34 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $233.75 | 2019-2021 | |
| Topcon Healthcare, INC. | $232.29 | 2021-2025 | |
| Allergan, INC. | $173.72 | 2022 | |
| Lkc Technologies, INC. | $165.27 | 2024-2025 | |
| Sight Sciences, INC. | $146.68 | 2023 | Tearcare System |
| Lumenis, INC | $119.75 | 2019 | |
| Sun Pharmaceutical Industries INC. | $109.57 | 2020-2025 | |
| Carl Zeiss Meditec USA, INC. | $105.53 | 2021 | |
| Oyster Point Pharma, INC. | $33.70 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $31.10 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.50 | 2023 | |
| Dompe US, INC. | $26.73 | 2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $14.77 | 2021 | |
| Oasis Medical, INC. | $12.92 | 2020 | |
| Abb Con-Cise Optical Group LLC | $9.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristy Dehoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.